Kalender
Est. tid* | ||
2026-01-28 | 08:00 | Bokslutskommuniké 2025 |
2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
2025-05-06 | - | Årsstämma |
2025-04-23 | - | Kvartalsrapport 2025-Q1 |
2025-02-28 | - | Bokslutskommuniké 2024 |
2025-02-13 | - | Extra Bolagsstämma 2025 |
2024-10-22 | - | Kvartalsrapport 2024-Q3 |
2024-07-16 | - | Kvartalsrapport 2024-Q2 |
2024-05-08 | - | X-dag ordinarie utdelning PROB 1.30 SEK |
2024-05-07 | - | Årsstämma |
2024-04-23 | - | Kvartalsrapport 2024-Q1 |
2024-01-26 | - | Bokslutskommuniké 2023 |
2023-10-24 | - | Kvartalsrapport 2023-Q3 |
2023-07-18 | - | Kvartalsrapport 2023-Q2 |
2023-05-05 | - | X-dag ordinarie utdelning PROB 1.30 SEK |
2023-05-04 | - | Årsstämma |
2023-04-26 | - | Kvartalsrapport 2023-Q1 |
2023-01-27 | - | Bokslutskommuniké 2022 |
2022-10-21 | - | Kvartalsrapport 2022-Q3 |
2022-07-15 | - | Kvartalsrapport 2022-Q2 |
2022-05-06 | - | X-dag ordinarie utdelning PROB 1.30 SEK |
2022-05-05 | - | Årsstämma |
2022-04-26 | - | Kvartalsrapport 2022-Q1 |
2022-02-02 | - | Bokslutskommuniké 2021 |
2021-10-22 | - | Kvartalsrapport 2021-Q3 |
2021-07-26 | - | Kvartalsrapport 2021-Q2 |
2021-05-10 | - | X-dag ordinarie utdelning PROB 1.10 SEK |
2021-05-07 | - | Årsstämma |
2021-04-23 | - | Kvartalsrapport 2021-Q1 |
2021-02-09 | - | Bokslutskommuniké 2020 |
2020-10-21 | - | Kvartalsrapport 2020-Q3 |
2020-07-17 | - | Kvartalsrapport 2020-Q2 |
2020-05-14 | - | X-dag ordinarie utdelning PROB 1.00 SEK |
2020-05-13 | - | Årsstämma |
2020-04-24 | - | Kvartalsrapport 2020-Q1 |
2020-02-11 | - | Bokslutskommuniké 2019 |
2019-10-25 | - | Kvartalsrapport 2019-Q3 |
2019-07-19 | - | Kvartalsrapport 2019-Q2 |
2019-05-08 | - | X-dag ordinarie utdelning PROB 0.00 SEK |
2019-05-07 | - | Årsstämma |
2019-04-29 | - | Kvartalsrapport 2019-Q1 |
2019-02-13 | - | Bokslutskommuniké 2018 |
2018-11-06 | - | Kvartalsrapport 2018-Q3 |
2018-08-13 | - | Kvartalsrapport 2018-Q2 |
2018-05-03 | - | X-dag ordinarie utdelning PROB 0.00 SEK |
2018-05-02 | - | Årsstämma |
2018-05-02 | - | Kvartalsrapport 2018-Q1 |
2018-01-25 | - | Bokslutskommuniké 2017 |
2017-10-25 | - | Kvartalsrapport 2017-Q3 |
2017-07-19 | - | Kvartalsrapport 2017-Q2 |
2017-05-05 | - | X-dag ordinarie utdelning PROB 1.00 SEK |
2017-05-04 | - | Kvartalsrapport 2017-Q1 |
2017-01-24 | - | Bokslutskommuniké 2016 |
2016-10-18 | - | Kvartalsrapport 2016-Q3 |
2016-07-15 | - | Kvartalsrapport 2016-Q2 |
2016-06-29 | - | Extra Bolagsstämma 2016 |
2016-04-28 | - | X-dag ordinarie utdelning PROB 1.00 SEK |
2016-04-27 | - | Årsstämma |
2016-04-27 | - | Kvartalsrapport 2016-Q1 |
2016-01-26 | - | Bokslutskommuniké 2015 |
2015-10-22 | - | Kvartalsrapport 2015-Q3 |
2015-07-16 | - | Kvartalsrapport 2015-Q2 |
2015-04-24 | - | X-dag ordinarie utdelning PROB 0.85 SEK |
2015-04-23 | - | Årsstämma |
2015-04-23 | - | Kvartalsrapport 2015-Q1 |
2015-01-28 | - | Bokslutskommuniké 2014 |
2014-10-29 | - | Analytiker möte 2014 |
2014-10-29 | - | Kvartalsrapport 2014-Q3 |
2014-08-19 | - | Kvartalsrapport 2014-Q2 |
2014-04-30 | - | X-dag ordinarie utdelning PROB 0.75 SEK |
2014-04-29 | - | Årsstämma |
2014-04-29 | - | Kvartalsrapport 2014-Q1 |
2014-01-23 | - | Bokslutskommuniké 2013 |
2013-10-22 | - | Kvartalsrapport 2013-Q3 |
2013-08-20 | - | Kvartalsrapport 2013-Q2 |
2013-04-25 | - | X-dag ordinarie utdelning PROB 0.75 SEK |
2013-04-24 | - | Årsstämma |
2013-04-24 | - | Kvartalsrapport 2013-Q1 |
2013-01-24 | - | Bokslutskommuniké 2012 |
2012-10-18 | - | Kvartalsrapport 2012-Q3 |
2012-09-28 | - | Kapitalmarknadsdag 2012 |
2012-08-16 | - | Kvartalsrapport 2012-Q2 |
2012-04-26 | - | Årsstämma |
2012-04-26 | - | Kvartalsrapport 2012-Q1 |
2012-01-25 | - | Bokslutskommuniké 2011 |
2011-10-19 | - | Kvartalsrapport 2011-Q3 |
2011-07-19 | - | Kvartalsrapport 2011-Q2 |
2011-04-29 | - | X-dag bonusutdelning PROB 0.5 |
2011-04-29 | - | X-dag ordinarie utdelning PROB 0.50 SEK |
2011-04-28 | - | Årsstämma |
2011-04-28 | - | Kvartalsrapport 2011-Q1 |
2011-01-26 | - | Bokslutskommuniké 2010 |
2010-10-20 | - | Kvartalsrapport 2010-Q3 |
2010-07-20 | - | Kvartalsrapport 2010-Q2 |
2010-04-23 | - | X-dag ordinarie utdelning PROB 0.50 SEK |
2010-04-22 | - | Årsstämma |
2010-04-22 | - | Kvartalsrapport 2010-Q1 |
2010-01-27 | - | Bokslutskommuniké 2009 |
2009-10-21 | - | Kvartalsrapport 2009-Q3 |
2009-08-18 | - | Kvartalsrapport 2009-Q2 |
2009-05-07 | - | X-dag ordinarie utdelning PROB 0.00 SEK |
2009-05-06 | - | Årsstämma |
2009-04-22 | - | Kvartalsrapport 2009-Q1 |
Beskrivning
Land | Sverige |
---|---|
Sektor | Hälsovård |
Industri | Läkemedel & Handel |
Probi is proud to announce that Probi® Female has won the NutraIngredients Award 2025 in the category Innovation in Women's Health. The award was presented live at Vitafoods Europe in Barcelona, celebrating scientific excellence and commercial impact in the global health and nutrition industry.
"We're incredibly proud and truly honored," says Martina Pettersson, Global Marketing Director at Probi.
"This recognition underscores both the strength of the product and the importance of science-driven innovation in women's health. The response has been outstanding, and this award marks an important milestone in our ongoing international expansion."
A science-driven solution for a global health challenge
Probi Female is a unique direct-to-consumer product formulated specifically for women. It combines Probi's proprietary strain Lactiplantibacillus plantarum 299v (LP299V®) with iron, folic acid, and vitamin C - designed to increase iron absorption, support iron levels, and reduce the common gastrointestinal side effects associated with traditional iron supplementation.
The strength of this solution is rooted in science, according to Caroline Montelius, Department Manager Scientific Affairs at Probi:
"The LP299V strain is one of the most researched probiotic strains in the world, and its ability to enhance iron absorption has been demonstrated in multiple clinical trials. We are proud to see this achievement recognized on an international level."
According to the World Health Organization, iron deficiency remains a serious global health concern, particularly affecting women of reproductive age. WHO estimates that 30 percent of women aged 15-49 worldwide are anaemic, with even higher rates among pregnant women and young children.
Probi Female is available as a consumer product across the Nordics and is also offered as a functional ingredient to our global B2B partners.
What the judges said
"Probi® Female takes a unique probiotic approach to reducing iron deficiency. This novel solution combines L. plantarum 299v with iron, enhancing absorption and reducing side effects, as scientifically proven in extensive clinical trials. With over 30% of women affected by iron deficiency, Probi Female addresses a critical unmet need, offering a more effective and tolerable iron supplement that empowers women to feel their best."
For further information, please contact:
Lisa Jalakas, Global Content Strategy Manager, lisa.jalakas@probi.com